2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 25689628 | Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself. | 2015 | 4 |
| 2 | 19789326 | Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo? | 2009 Oct 1 | 1 |